Scientists at the University of Southampton have made a significant discovery in efforts to develop a vaccine against Zika, dengue and Hepatitis C viruses that affect millions of people around the world.
In a study published in Science Immunology, researchers have shown that natural killer cells (NK cells), which are a fundamental part of the body’s immune system, can recognise many different viruses including global pathogens such as Zika, dengue and Hepatitis C viruses, through a single receptor called KIR2DS2.
Lead researcher Salim Khakoo, Professor of Hepatology, said the findings are very exciting and could change the way viruses are targeted by vaccines but warned that the research is still at an early stage, and animal studies/clinical trials will be needed to test the findings.
Vaccines work by stimulating the immune response to the coat of proteins on the virus enabling the body to fight off the virus and recognise it in the future. However, the viruses are able to change their coat proteins, helping the virus to evade the antibodies, meaning some viruses can be very hard to vaccinate against.
The Southampton team have shown that this NK cell receptor is able to target a non-variable part of the virus called the NS3 helicase protein, which is essential in making the virus work properly. Unlike other proteins, the NS3 helicase protein does not change, which allows the immune system to grab hold of it and let the NK cells deal with the threat.
Professor Khakoo said: “The NS3 helicase protein could be the key in unlocking the defence of lethal viruses that affect so many people around the world. It is very exciting to discover that other viruses similar to Hepatitis C, such as Zika virus, dengue virus, yellow fever virus, Japanese encephalitis virus and in fact all flaviviruses, contain a region within their NS3 helicase proteins that is recognised by exactly the same KIR2DS2 receptor. We believe that by targeting this NS3 helicase region, we could make a new type of vaccine based upon natural killer cells, which can be used to help protect people from these infections.”
The study, which was funded by the Wellcome Trust and the Medical Research Council, analysed DNA from more than 300 patients exposed to the Hepatitis C virus, which showed that the KIR2DS2 receptor was associated with successfully clearing the virus. The team then identified that the immune system targeted the NS3 helicase protein of this using the receptor and found that it prevented the virus multiplying.
They went on to demonstrate that this same mechanism icould be important for many different viruses for example the Zika and dengue viruses, which also contain a region within their NS3 helicase protein that is recognised by the KIR2DS2 receptor.
The researchers now need to determine whether these KIR2DS2+ NK cells are protective during acute flaviviral infections, and are hoping to develop a vaccine that targets natural killer cells. They believe that a similar process could be used to target cancer.
Professor Khakoo added: “Cancer treatments that use the body’s own immune system are becoming more common. Our findings present a completely new strategy for virus therapeutics which could be easily translated into the field of cancer. The next few years are going to be very exciting in this field.”
The Latest on: Vaccine for viruses
[google_news title=”” keyword=”vaccine for viruses” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
- A New COVID Vaccine Dose Is Now Available for People Age 65 and Older. Where Can You Find a Shot Near You?on March 2, 2024 at 4:04 am
So for most people with health insurance, their insurer will now cover the cost of getting the new COVID vaccine direct, much like your plan might cover your flu shot — and this is why many county ...
- Polio Day on March 3, 2024: 5 benefits of polio vaccine for your kidon March 1, 2024 at 11:10 pm
Polio Day will be observed across the country with a nationwide Pulse Polio Immunization drive on March 3. Know benefits of polio vaccine for your kid.
- New antibodies target “dark side” of influenza virus proteinon March 1, 2024 at 4:00 pm
The research, led by scientists at the National Institute of Allergy and Infectious Diseases’ Vaccine Research Center, part of NIH, was published today in Immunity. Influenza, or flu, sickens millions ...
- CDC: Flu vaccines have helped this year, but New Mexico is still seeing elevated flu levelson March 1, 2024 at 1:30 pm
Flu vaccines have helped reduce nationwide hospital visits, according to the U.S. Centers for Disease Control and Prevention (CDC). However, data shows New Mexico is still seeing high levels of ...
- 2023 to 2024 seasonal influenza vaccine effective for reducing risk, research findson March 1, 2024 at 2:40 am
The 2023 to 2024 seasonal influenza vaccine is effective for reducing the risk for medically attended influenza virus infection, according to research published in the Feb. 29 issue of the U.S.
- U.S. flu vaccines expected to shift from quadrivalent to trivalent, researcher sayson February 29, 2024 at 1:04 pm
U.S. flu vaccines are likely to move from quadrivalent to trivalent due to a change in circulating influenza viruses, says a University of Michigan researcher.
- Pfizer's Respiratory Syncytial Virus Vaccine Maintains Staying Power In Older Adults Through 2nd RSV season, Study Findson February 29, 2024 at 11:04 am
Pfizer Inc (NYSE:PFE) announced top-line Abrysvo vaccine efficacy and safety data for respiratory syncytial virus (RSV) in adults 60 years of age and older following a second season in the Northern ...
- Pfizer RSV vaccine protects for more than 2 seasons in older adults: Researchon February 29, 2024 at 10:30 am
Pfizer announced Thursday that its vaccine for RSV, or respiratory syncytial virus, protects older adults for more than two seasons, according to a late-stage clinical trial. Pfizer announced that its ...
- US numbers indicate flu shots are performing acceptably against viruson February 28, 2024 at 5:19 pm
Estimates early for the 2023-24 flu season show that the vaccine is doing a fair job in preventing adults from falling sick enough to require a doctor's visit.
- Flu vaccine offering decent levels of protection this winter, new data showon February 28, 2024 at 3:59 pm
Flu vaccine appears to be offering reasonable levels of protection this winter, with particularly strong levels in children, new data from the Centers for Disease Control and Prevention suggest. The ...
via Google News and Bing News